Roth Capital Equities Analysts Cut Earnings Estimates for Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Stock analysts at Roth Capital decreased their Q1 2025 earnings estimates for Bioceres Crop Solutions in a research report issued to clients and investors on Wednesday, September 11th. Roth Capital analyst S. Fortune now anticipates that the company will earn $0.04 per share for the quarter, down from their prior estimate of $0.21. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.81 per share. Roth Capital also issued estimates for Bioceres Crop Solutions’ Q2 2025 earnings at $0.09 EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at $0.13 EPS, FY2025 earnings at $0.25 EPS and FY2026 earnings at $0.63 EPS.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The business had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. During the same period last year, the company earned ($0.06) EPS.

Several other research analysts have also issued reports on BIOX. Roth Mkm dropped their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Oppenheimer decreased their price objective on shares of Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating on the stock in a research note on Wednesday. Canaccord Genuity Group decreased their price target on shares of Bioceres Crop Solutions from $17.00 to $12.50 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Lake Street Capital decreased their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $13.63.

Bioceres Crop Solutions Stock Performance

NASDAQ:BIOX opened at $8.56 on Friday. Bioceres Crop Solutions has a 12-month low of $8.16 and a 12-month high of $14.05. The company has a quick ratio of 0.83, a current ratio of 1.28 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $537.57 million, a PE ratio of 856.00 and a beta of 0.49. The firm has a 50-day moving average price of $10.43 and a 200 day moving average price of $11.41.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several large investors have recently bought and sold shares of BIOX. Cape Investment Advisory Inc. acquired a new position in Bioceres Crop Solutions in the fourth quarter valued at approximately $33,000. Wellington Management Group LLP lifted its holdings in Bioceres Crop Solutions by 3.1% in the fourth quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock valued at $3,253,000 after buying an additional 7,096 shares during the period. Fourth Sail Capital LP raised its holdings in Bioceres Crop Solutions by 136.1% in the first quarter. Fourth Sail Capital LP now owns 1,627,630 shares of the company’s stock worth $20,606,000 after purchasing an additional 938,282 shares during the period. Activest Wealth Management acquired a new stake in Bioceres Crop Solutions in the first quarter worth $30,000. Finally, Oppenheimer & Co. Inc. acquired a new stake in Bioceres Crop Solutions in the first quarter worth $139,000. 17.68% of the stock is currently owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.